HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
TORONTO, May 06, 2024 (GLOBE NEWSWIRE) — HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX:AIDX) is pleased to announce today that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Eight Capital Corp. (“Eight”), as Co-Bookrunners and Co-Lead Underwriters (the “Co-Lead Underwriters”), on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its previously announced C$16,000,065 “bought deal” offering. Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a “bought deal” basis 12,592,600 units of the Company (the “Units”) at a price of C$1.35 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of C$17,000,010 (the “Offering”).
Related news for (HWAIF)
- HEALWELL AI Leverages Orion Health to Power Entry into US Market
- WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program
- HEALWELL AI to Announce Fiscal First Quarter 2025 Financial Results on May 13, 2025
- WELL Health to Exercise Call Right and Acquire Majority Controlling Interest in HEALWELL AI concurrent with HEALWELL’s Proposed Acquisition of Orion Health
- HEALWELL AI to Announce Fourth Quarter and Year End 2024 Financial Results on March 26, 2025